Health
Insilico Medicine AI COVID tool uses Xeons – Fudzilla
Intel helps in COVID-19 research Industry veteran Alex Zhavoronkov who left the PC industry (ATI and AMD) to start the AI longevity focused Insilico Medicine, has announced AI-powered COVIDomic to power the COVID-19 basic and clinical research.
Insilico Medicine is a global leader in artificial intelligence for drug discovery and development, and the company is among the first in the world to embrace the AI technologies in tools in drug discoveries. Now the company realized that it could use AI on Intel Xeon architecture to launch a new system for COVID-19 basic and clinical research.
Insilico Medicine came up with COVIDomic, a foundational technology that enables scientists to use anonymized patient data to integrate with a variety o…
-
General23 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General15 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
Noosa News14 hours agoE-Scooter accident | Noosa Today
-
General17 hours agoOscars to move to free streaming on YouTube in 2029